Navigation Links
Despite recession, children's health spending increased between 2009-2012, says new report
Date:2/26/2014

Washington, DC Spending on health care for children covered by employer-sponsored insurance (ESI) increased between 2009 and 2012, rising an average 5.5 percent a year, with more dollars spent on boys than girls, and higher spending on infants and toddlers (ages 0-3) than any other children's age group, finds a new report released today by the Health Care Cost Institute (HCCI). Per capita spending on children reached $2,437 in 2012, a $363 increase from 2009. The study shows a growth in prescription use by children through age 18, as well as a rise in the number of teens being admitted for mental health and substance use (MHSU) treatment.

The report, Children's Health Spending: 2009-2012, presents the most up-to-date data on health care spending trends for privately insured children under age 19. It is based on fee-for-service claims for 10.5 million children per year who were covered by employer-sponsored health insurance (ESI). For all years studied, HCCI found rising prices contributed more to spending growth than did utilization of services. However, increased prescription use contributed to rising spending for children over the age of 3.

Big Gender Gap in Spending

Until age 14, boys had higher health care spending than girls, and boys of all ages had a higher share of spending on brand prescriptions. In 2012, spending for boys reached $2,572, while spending on girls was $2,296 a $276 gender difference. Out-of-pocket spending also was higher for boys than for girls, $440 per boy and $414 per girl. When children reached their teens, spending on health care for girls was higher than boys, a trend that continues throughout adulthood until about age 60.

Rise in Prescription Use and Teen Mental Health Admissions

All age groups saw increased overall prescription spending in 2011 and 2012, according to the report. The most common prescription drug class was central nervous system (CNS) agents (commonly associated with attention deficit hyperactivity disorder, anxiety, and depression). Use of CNS drugs by younger children (ages 4-8), pre-teens (ages 9-13), and teens (ages 14-18) rose over time, and in each age group boys had higher use of CNS drugs than girls. Between 2011 and 2012, younger children, pre-teens, and teenagers saw double-digit growth in generic CNS use.

Teen girls had higher levels of overall prescription use than teen boys. In 2012, teen boys used an average 89 filled days of brand and generic prescriptions; in contrast, teen girls averaged 128 filled days. The difference in prescription usage between boys and girls was largely a result of teen girls' use of synthetic hormones (typically associated with birth control pills).

"The trend of rising use of prescriptions among children is particularly notable," says HCCI Executive Director David Newman. "We, and others, need to focus on the mental health needs of our children."

Other report highlights:

  • Infants and Toddlers: For infants and toddlers, per child spending was $4,446 in 2012, and was largely driven by visits to doctors' offices and hospital care for the sickest newborns. Hospitalizations accounted for nearly 40% of spending per baby.

  • Younger Children and Pre-Teens: Possibly triggered by the recession, health care spending growth dipped temporarily in 2010, due in large part to decreased use of health care services. In 2010, outpatient visits to emergency rooms declined for all children, with the most pronounced declines for younger children and pre-teens.

  • Teen Use of Mental Health and Substance Use (MHSU) Services Grew: There was rising use of mental health services by teens, and there were more MHSU admissions for girls than for boys in all years studied. For girls, use rose from 9 admits per 1,000 teen girls in 2010 to 11 in 2012; for boys, MHSU admits rose from 7 per 1,000 teen boys in 2010 to 9 in 2012.

  • Out-of-Pocket Spending Rose: Slightly more than 17 percent of health care spending per child was paid out of pocket between 2009 and 2012, with out-of-pocket spending growing fastest in the Midwest and the South.

  • Prescription Spending Growth: In 2012, spending on prescriptions for children rose 7.1 percent, 2.1 percentage points faster than in 2011, and 2.3 percentage points faster than in 2010. Higher prescription expenditure growth was driven mainly by rising use of generics.

  • Spike in Meningitis Vaccines Among Teens: Federal policies may have helped prompt a 47.6 percent spike in meningitis vaccination rates among teens in 2011, and an additional 16.4 percent increase in 2012. These increases were likely due to vaccine recommendations promulgated by the Centers for Disease Control and Prevention and benefit changes under the Affordable Care Act.

"We hope this report illustrates where health care spending for children is occurring," says HCCI Senior Researcher Amanda Frost. "While we know that prices have fueled health care spending growth, this report shows where those dollars are going to help identify implications for children's health and care."

The Children's Health Spending: 2009-2012 will be available on the Health Care Cost Institute's website on February 27, 2014 at 12:01 a.m. ET at: http://www.healthcostinstitute.org/childrens-health-spending-2009-2012.


'/>"/>

Contact: Maya Brod
mbrod@burnesscommunications.com
301-280-5757
Burness Communications
Source:Eurekalert

Related medicine news :

1. Many Still Tanning, Despite Dangers, Survey Finds
2. Despite less play, childrens use of imagination increases over 2 decades
3. Despite hardships, black men in urban communities are resilient, MU researcher says
4. Despite clear benefits, heart failure clinics are rarely utilized
5. Seniors Creativity Can Thrive Despite Dementia
6. Undertreatment of common heart condition persists despite rapid adoption of novel therapies
7. Ethnic disparities in breast cancer survival remain despite socioeconomic similarities
8. Pneumonia remains the leading killer of children despite decline in global child deaths
9. Despite FDA Warning, Sports Supplements Still Available Online: Study
10. Despite hype, costly prostate cancer treatment offers little relief from side effects
11. Many U.S. Teens at Risk for Suicide Despite Treatment: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... ... Pastor and Overseer at The House of Yahweh in Abilene, Texas, has published a new ... not. Yisrayl says with so many titles and names for the Creator, it’s hard ... a little Scripture, backed with a lot of research, the truth is undeniable. , ...
(Date:4/28/2017)... ... April 28, 2017 , ... Woolsy Corporation Limited, a ... its Nova Skin Sciences division, recently announced the launch of Allumière Antiaging Cream, ... power of an anti-aging concentrate. , Anogeissus Leiocarpa Bark Extract and ...
(Date:4/28/2017)... Tenn. (PRWEB) , ... April 28, 2017 , ... ... system, today announced an alliance with B. Braun Medical Inc. , a leader ... role in patient care with as many as 90 percent of hospital patients receiving ...
(Date:4/27/2017)... , ... April 27, 2017 , ... ... natural deodorant. On the heels of Thinksport’s award-winning sunscreen they’ve used the same ... that actually works! , Countless deodorants flood the aisles that contain harmful chemicals ...
(Date:4/27/2017)... ... April 27, 2017 , ... Goodcents Deli Fresh Subs announced ... Lincoln, Neb. area this year. , The first new location will open at ... will open at 84th and Northern Lights Drive this fall. And the third location ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... NEW YORK , April 19, 2017 /PRNewswire/ ... This report on the prostate cancer ... of the global market. Increasing prevalence of prostate ... as innovation in the development of new drugs ... hormone-refractory prostate cancer drug due to lesser side ...
(Date:4/19/2017)... April 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... biopharmaceutical company developing new treatments for cancer and ... of its previously announced underwritten public offering of ... public offering price of $2.00 per share, before ... expenses payable by Sorrento.  The net proceeds to ...
(Date:4/19/2017)... N.J. , April 19, 2017  Novartis ... by the National Heart, Lung, and Blood Institute ... demonstrating that 58% of patients with treatment-naïve severe ... months when treated with eltrombopag at the initiation ... . The study evaluated three sequential treatment groups, ...
Breaking Medicine Technology: